Clinton Heyer
Podiatrist · Indianapolis, INNPI 1881219913
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (54.1%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Stryker at 38.2% of the total. Reporting peaked in 2023 at $3,307 and has fallen 54.4% since, to $1,508 in 2025.
Across 120 payments — averaging $67.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Skye Orthobiologics LLC$2K
- Johnson & Johnson$1K
- Crossroads Orthopedics, LLC$997
- Integra Lifesciences Corporation$526
- Arthrex$478
- plus $505 from 5 others
Across 1 payment — averaging $1500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Skye Orthobiologics LLC$2K
What the payments were for
- Speaking & faculty fees$1,50018%
- Travel & lodging$2,22027%
- Food & beverage$4,39254%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 52 | $3,101 |
| Skye Orthobiologics LLC | 1 | $1,500 |
| Johnson & Johnson | 15 | $1,005 |
| Crossroads Orthopedics, LLC | 9 | $997 |
| Integra Lifesciences Corporation | 12 | $526 |
| Arthrex | 11 | $478 |
| Smith+Nephew | 12 | $356 |
| Paragon 28, Inc. | 4 | $72 |
| Kerecis Limited | 2 | $33 |
| Abbott | 1 | $24 |
| Biocomposites Inc | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,112 in reported general payments places this provider in the 85th percentile of 131 podiatrist providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 42 | $392 |
| Doxycycline Monohydrate | 15 | $285 |
| Terbinafine Hcl | 16 | $217 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 11 | $148 |
| Doxycycline Hyclate | 12 | $107 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $75 |
| Meloxicam | 17 | $55 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Indianapolis
- Anthony MillerIndianapolis$292K
- Corey GrohIndianapolis$57K
- Jeffrey StevensIndianapolis$56K
- Lynette MeeceIndianapolis$5K
- Jeremy SpauldingIndianapolis$4K
- Kenneth StumpfIndianapolis$4K
- Austin QuebedeauxIndianapolis$3K
- Elizabeth MorrisonIndianapolis$2K
- Todd MannIndianapolis$2K
- Craig ShouseIndianapolis$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.